Daniel Busby
Stock Analyst at RBC Capital
(2.58)
# 2,160
Out of 5,122 analysts
6
Total ratings
66.67%
Success rate
22.25%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Daniel Busby
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VRCA Verrica Pharmaceuticals | Downgrades: Sector Perform | $160 → $40 | $7.39 | +441.27% | 2 | May 25, 2022 | |
| PFE Pfizer | Maintains: Sector Perform | $43 → $44 | $25.77 | +70.74% | 1 | Jun 17, 2021 | |
| MNKD MannKind | Initiates: Sector Perform | $5 | $6.21 | -19.48% | 2 | May 14, 2021 | |
| ABBV AbbVie | Reiterates: Outperform | $135 | $225.66 | -40.18% | 1 | May 3, 2021 |
Verrica Pharmaceuticals
May 25, 2022
Downgrades: Sector Perform
Price Target: $160 → $40
Current: $7.39
Upside: +441.27%
Pfizer
Jun 17, 2021
Maintains: Sector Perform
Price Target: $43 → $44
Current: $25.77
Upside: +70.74%
MannKind
May 14, 2021
Initiates: Sector Perform
Price Target: $5
Current: $6.21
Upside: -19.48%
AbbVie
May 3, 2021
Reiterates: Outperform
Price Target: $135
Current: $225.66
Upside: -40.18%